Acton, MA, United States of America

Alan J Bitonti

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 3.2

ph-index = 15

Forward Citations = 934(Granted Patents)


Location History:

  • Cincinnati, OH (US) (1997)
  • Maineville, OH (US) (1990 - 2000)
  • Ringoes, NJ (US) (2002)
  • Annapolis, MD (US) (2016)
  • Action, MA (US) (2017)
  • Acton, MA (US) (2002 - 2022)

Company Filing History:


Years Active: 1990-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chimeric Polypeptides
Immunoglobulin Hybrids
Clotting Factors
Fc Receptor Binding Proteins
Hemophilia Treatments
Cyclic Antiplatelet Peptides
Triaryl-Ethylene Derivatives
Antiangiogenic Oligomers
Polyamine Derivatives
Estrogen-Related Neoplasms
Drug-Resistant Malaria Treatments
Carcinoma Treatments
43 patents (USPTO):Explore Patents

Title: The Innovative Mind of Alan J Bitonti: Revolutionizing the Biotechnology Industry

Introduction: Alan J Bitonti, a brilliant inventor hailing from Acton, MA, has left an indelible mark on the field of biotechnology with his impressive portfolio of 25 patents.

Latest Patents: Alan's recent patents include groundbreaking inventions such as the Immunoglobulin chimeric monomer-dimer hybrids and Factor VIII-FC chimeric and hybrid polypeptides. These innovations have paved the way for novel methods in protein engineering and biopharmaceuticals.

Career Highlights: Throughout his career, Alan J Bitonti has made significant contributions to the biotechnology sector. He has worked with esteemed companies like Syntonix Pharmaceuticals, Inc. and Bioverativ Therapeutics Inc., where his inventive spirit thrived.

Collaborations: Alan has collaborated closely with talented individuals in the field, such as Robert T Peters and Susan C Low. Their combined efforts have led to the development of cutting-edge technologies that have reshaped the landscape of biopharmaceutical research.

Conclusion: Alan J Bitonti's dedication to innovation and relentless pursuit of scientific excellence have positioned him as a trailblazer in the realm of biotechnology. His patents stand as a testament to his ingenuity and unwavering commitment to pushing the boundaries of what is possible in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…